Related Experiment Video
Updated: Oct 21, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis
Roarke A Kamber1, Yoko Nishiga1,2,3, Bhek Morton1
1Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Abstract:
Monoclonal antibody therapies targeting tumour antigens drive cancer cell elimination in large part by triggering macrophage phagocytosis of cancer cells1-7. However, cancer cells evade phagocytosis using mechanisms that are incompletely understood. Here we develop a platform for unbiased identification of factors that impede antibody-dependent cellular phagocytosis (ADCP) using complementary genome-wide CRISPR knockout and overexpression screens in both cancer cells and macrophages. In cancer cells, beyond known factors such as CD47, we identify many regulators of susceptibility to ADCP, including the poorly characterized enzyme adipocyte plasma membrane-associated protein (APMAP). We find that loss of APMAP synergizes with tumour antigen-targeting monoclonal antibodies and/or CD47-blocking monoclonal antibodies to drive markedly increased phagocytosis across a wide range of cancer cell types, including those that are otherwise resistant to ADCP. Additionally, we show that APMAP loss synergizes with several different tumour-targeting monoclonal antibodies to inhibit tumour growth in mice. Using genome-wide counterscreens in macrophages, we find that the G-protein-coupled receptor GPR84 mediates enhanced phagocytosis of APMAP-deficient cancer cells. This work reveals a cancer-intrinsic regulator of susceptibility to antibody-driven phagocytosis and, more broadly, expands our knowledge of the mechanisms governing cancer resistance to macrophage phagocytosis.
Insights
Researchers identified adipocyte plasma membrane-associated protein (APMAP) as a key factor enabling cancer cells to evade macrophage phagocytosis. Loss of APMAP enhances cancer cell elimination by immunotherapy, offering new therapeutic strategies.
Area of Science:
- Immunology
- Cancer Biology
- Genetics
Background:
- Monoclonal antibody therapies eliminate cancer cells by stimulating macrophage phagocytosis.
- Cancer cells possess incompletely understood mechanisms to evade phagocytosis, limiting therapeutic efficacy.
Purpose of the Study:
- To identify novel factors that regulate cancer cell susceptibility to antibody-dependent cellular phagocytosis (ADCP).
- To uncover mechanisms of cancer cell resistance to phagocytosis mediated by macrophages.
Main Methods:
- Development of a platform for unbiased, genome-wide CRISPR knockout and overexpression screens in cancer cells and macrophages.
- Identification of ADCP regulators using complementary screening approaches.
Main Results:
- Adipocyte plasma membrane-associated protein (APMAP) was identified as a novel regulator of ADCP in cancer cells.
- Loss of APMAP significantly enhanced phagocytosis of various cancer cells, including ADCP-resistant types, when combined with tumor antigen-targeting or CD47-blocking antibodies.
- APMAP loss synergized with tumor-targeting monoclonal antibodies to inhibit tumor growth in vivo.
- G-protein-coupled receptor GPR84 was found to mediate enhanced phagocytosis of APMAP-deficient cancer cells by macrophages.
Conclusions:
- APMAP is a cancer-intrinsic factor that promotes resistance to antibody-driven phagocytosis.
- Targeting APMAP presents a promising strategy to overcome cancer cell evasion and enhance immunotherapy effectiveness.
- This study expands the understanding of macrophage phagocytosis regulation and cancer immune evasion mechanisms.
Related Concept Videos
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
The Extrinsic Apoptotic Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Antiviral System of Bacteria and Archaea: CRISPR

